Nuclear VHL:EloB,C:CUL2:RBX1 binds hydroxyprolyl-HIF-alpha

Stable Identifier
Reaction [binding]
Homo sapiens
Locations in the PathwayBrowser
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
The VHL component of the VHL:ElonginB:ElonginC:CUL2:RBX1 binds HIF-alpha that have hydroxylated proline residues (Cockman et al. 2000, Ohh et al. 2000, Tanimoto et al. 2000, Jaakkola et al. 2001, Ivan et al. 2001, Yu et al. 2001, Bonicalzi et al. 2001). The VHL:HIF-alpha complex is predominantly nuclear (Lewis and Roberts 2003) however binding and degradation of HIF-alpha can also occur in the cytosol (Berra et al. 2001).
Literature References
PubMed ID Title Journal Year
10823831 Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein

Masson, N, Chang, GW, Mole, DR, Jaakkola, P, Maxwell, PH, Cockman, ME, Maher, ER, Pugh, CW, Clifford, SC, Ratcliffe, PJ

J Biol Chem 2000
11024059 Role of exon 2-encoded beta -domain of the von Hippel-Lindau tumor suppressor protein

Lee, S, de Paulsen, N, Groulx, I, Bonicalzi, ME

J Biol Chem 2001
11454738 Hypoxia-inducible factor-1 alpha (HIF-1 alpha) escapes O(2)-driven proteasomal degradation irrespective of its subcellular localization: nucleus or cytoplasm

Pouysségur, J, Roux, D, Richard, DE, Berra, E

EMBO Rep 2001
10944113 Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein

Poellinger, L, Pereira, T, Tanimoto, K, Makino, Y

EMBO J 2000
10878807 Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein

Pavletich, N, Kim, TY, Park, CW, Ivan, M, Kaelin, WG, Ohh, M, Huang, LE, Hoffman, MA, Chau, V

Nat Cell Biol 2000
11292862 HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing

Lane, WS, Asara, JM, Kim, W, Salic, A, Valiando, J, Ivan, M, Kaelin WG, Jr, Ohh, M, Kondo, K, Yang, H

Science 2001
11292861 Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation

Gielbert, J, Gaskell, SJ, Maxwell, PH, Mukherji, M, Pugh, CW, Mole, DR, Kriegsheim, Av, Jaakkola, P, Tian, YM, Wilson, MI, Hebestreit, HF, Schofield, CJ, Ratcliffe, PJ

Science 2001
11504942 HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation

Yu, F, White, SB, Zhao, Q

Proc Natl Acad Sci U S A 2001
12821933 Role of nuclear and cytoplasmic localization in the tumour-suppressor activity of the von Hippel-Lindau protein

Roberts, BJ, Lewis, MD

Oncogene 2003
11358837 Dynamic, site-specific interaction of hypoxia-inducible factor-1alpha with the von Hippel-Lindau tumor suppressor protein

Yu, F, White, SB, Zhao, Q

Cancer Res 2001
9122164 The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins

Chen, DY, Worrell, RA, Burgess, WH, Lee, S, Linehan, WM, Klausner, RD, Pause, A

Proc Natl Acad Sci U S A 1997
12101228 Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclear-cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein

Lee, S, Groulx, I

Mol Cell Biol 2002
Orthologous Events
Cite Us!